Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

NCT05811247 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

OSA

Interventions

DRUG: AD109
DRUG: Placebo

Sponsor

Apnimed